CLINICAL AND LABORATORY FEATURES OF PATIENTS WITH COMORBID ASSOCIATION OF BRONCHIAL ASTHMA AND OBESITY
Clinical medicine

CLINICAL AND LABORATORY FEATURES OF PATIENTS WITH COMORBID ASSOCIATION OF BRONCHIAL ASTHMA AND OBESITY

Published 2021-08-30

Authors:

M.M. Kochuieva
V.G. Psarova
H.A. Tymchenko
O.S. Komissarova
A.V. Marchenko
M.Ye. Tymchenko
Yu.O. Zaikina

Abstract:
The relevance of the study is due to the increased prevalence of the phenotype of bronchial asthma with obesity and its more severe course. The purpose of the study was to investigate the effect of excess body weight on the parameters of the clinical and laboratory condition of patients with bronchial asthma. 132 patients with bronchial asthma (76 women and 56 men), aged 35–60 years, 30 patients with normal weight and 102 patients with a body mass index of 25.0 kg/m2 and more were examined. It was found that overweight patients with bronchial asthma have a longer duration of the disease (by 28.6 %) and corticosteroids (by 27.0 %), higher cardiovascular risk associated with increased diastolic blood pressure (by 5.3 %), decreased high-density lipoprotein (by 65.7 %), an increase in low-density lipoprotein (by 13.2 %) and glucose levels (by 5.1 %), an increase in interleukin-6 (by 31.8 %). Overweight correlations with age, spirometry, and symptom control were found in patients with asthma.
Keywords:
bronchial asthma obesity symptom control disease course cardiovascular risk
References:
  1. Bates JH, Poynter ME, Frodella CM, Peters U, Dixon AE, Suratt BT. Pathophysiology to phenotype in the asthma of obesity. Annals of the American Thoracic Society. 2017;14(Supplement_5). doi: 10.1513/annalsats.201702-122aw
  2. Carpaij OA, van den Berge M. The asthma–obesity relationship. Current Opinion in Pulmonary Medicine. 2018; 24(1):42–9. doi: 10.1097/mcp.0000000000000446
  3. Evans S, Kurukulaaratchy RJ. The effect of bariatric surgery in the Difficult ASTHMA–OBESITY Phenotype: A case report. Journal of Asthma. 82012; 50(1):52–5. doi: 10.3109/02770903.2012.741639
  4. Global initiative for asthma - global initiative for asthma [Internet]. GINA. 2021 [cited 2021Aug11]. Available from: https://ginasthma.org/
  5. Lang JE, Bunnell HT, Lima JJ, Hossain MJ, Wysocki T, Bacharier L, et al. Effects of age, sex, race/ethnicity, and allergy status in obesity‐related pediatric asthma. Pediatric Pulmonology. 2019;54(11):1684–93. doi: 10.1002/ppul.24470
  6. Michalovich D, Rodriguez-Perez N, Smolinska S, Pirozynski M, Mayhew D, Uddin S, et al. Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients. Nature Communications. 2019;10(1). doi: 10.1038/s41467-019-13751-9
  7. Miethe S, Karsonova A, Karaulov A, Renz H. Obesity and asthma. Journal of Allergy and Clinical Immunology. 2020;146(4):685–93. doi: 10.1016/j.jaci.2020.08.011
  8. Mohan A, Grace J, Wang BR, Lugogo N. The effects of obesity in asthma. Current Allergy and Asthma Reports. 2019; 19(10). doi: 10.1007/s11882-019-0877-z
  9. Peters U, Dixon A, Forno E. Obesity and Asthma. J Allergy Clin Immunol. 2018; 141(4):1169–79. doi: 10.1016/j.jaci.2018.02.004
  10. Villeneuve T, Guilleminault L. Asthme et obésité de l’adulte. Revue des Maladies Respiratoires. 2020; 37(1):60–74. doi: 10.1016/j.rmr.2019.03.016
  11. Wood LG. Asthma in the obese: A big and growing problem. American Journal of Respiratory and Critical Care Medicine. 2017; 195(1):4–5. doi: 10.1164/rccm.201608-1582ed
  12. Yuan Y, Ran N, Xiong L, Wang G, Guan X, Wang Z, et al. Obesity-related asthma: Immune regulation and potential targeted therapies. Journal of Immunology Research. 2018; 2018:1–13. doi: 10.1155/2018/1943497
Publication:
«World of Medicine and Biology» Vol. 17 No. 77 (2021) , с. 82-86
УДК 616.248-036.001.33